Smallcap rout: Over 900 shares fall as much as 41% this week. Natco, Senco amongst prime laggards

Out of the 938 shares within the BSE Smallcap index analysed by ETMarkets, 909 shares ended the week within the crimson with the very best fall of 41% witnessed in NGL Positive-Chem. The pharma firm has a market capitalisation of Rs 674 crore on the NSE and its shares ended at Rs 1,091 falling by over 7% on Friday.
Whereas shares akin to Natco Pharma, Harmony Biotech, Senco Gold and Nazara Applied sciences fell 33%, 27%, 28% and three% within the week passed by on weak quarterly outcomes others like Capacit’e Infraprojects (-10) and KNR Building (-13%) fell regardless of superior earnings.
Different main losers embody Orchid Pharma, KFin Applied sciences, Netweb Applied sciences India, Tilaknagar Industries, Delivery Company of India (SCI), Vijaya Diagnostic Centre, Zen Applied sciences, Bajaj Hindusthan Sugar, Swan Power and Roto Pumps.
Additionally Learn: Unfazed by Trump tantrums, FII sell-off, these 13 shares ship double-digit returns thus far in 2025, outshine gold
There have been gainers too as 29 smallcap shares managed to finish the week on a optimistic notice.
The leaders within the pack included Garware Hello-Tech Movies (15%), Kennametal India (12%) and Godfrey Phillips India (9%) because the Road cheered their earnings.
Shares like Honasa Client (mamaearth), Ingersoll-Rand (India), Inox Wind, Happiest Minds Applied sciences and Triveni Turbine managed to stay affloat within the inexperienced with weekly returns between 4% and 1%.
SBI Securities in a notice known as Trump’s reciprocal tariffs on all its buying and selling companions a serious cause behind market debacle.
Furthermore, the promoting pattern by Overseas Institutional Buyers (FIIs) additionally performed its half, mentioned this brokerage highlighting equities price Rs 14,152 crore had been offered throughout the week however a Rs 18,745 crore buy by the home institutional buyers (DIIs).
In its advice, SBI Securities suggested buyers to stay to high quality companies with supportive valuations for medium to long run funding horizon.
(Disclaimer: Suggestions, strategies, views and opinions given by the consultants are their very own. These don’t characterize the views of Financial Occasions)